| 2933.39.61 | 10 | 3-Quinuclidinyl benzilate | kg | | | |
| 2933.41.00 | 00 | Compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2933.49.17 | 00 | Ethyl ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylate | kg | Free | | 15.4￠/kg + 52% |
| 2933.49.20 | 00 | 5-Chloro-7-iodo-8-quinolinol (Iodochlorhydroxyquin); Decoquinate; Diiodohydroxyquin; and Oxyquinoline sulfate | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 46% |
| 2933.52 | | Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure: | | | | |
| 2933.54.00 | 00 | Other derivatives of malonylurea (barbituric acid); salts thereof | kg | 3.7% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P, SG) | 50% |
| 2933.59.10 | 00 | Aromatic or modified aromatic: | | | | |
| 2933.59.21 | 00 | Aromatic or modified aromatic: | | | | |
| 2933.59.70 | 00 | Aromatic or modified aromatic: | | | | |
| 2933.61.00 | 00 | Compounds containing an unfused triazine ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.69.60 | 15 | Sodium dichloroisocyanurate and trichloroisocyanuric acid | kg | | | |
| 2933.79.04 | 00 | Aromatic or modified aromatic: | | | | |
| 2933.91.00 | 00 | Alprazolam (INN), camazepam (INN), chlordiazepoxide (INN), clonazepam (INN), clorazepate, delorazepam (INN), diazepam (INN), estazolam (INN), ethyl loflazepate (INN), fludiazepam (INN), flunitrazepam (INN), flurazepam (INN), halazepam (INN), lorazepam (INN), lormetazepam (INN), mazindol (INN), medazepam (INN), midazolam (INN), nimetazepam (INN), nitrazepam (INN), nordazepam (INN), oxazepam (INN), pinazepam (INN), prazepam (INN), pyrovalerone (INN), temazepam (INN), tetrazepam (INN) and triazolam (INN); salts thereof | kg | Free | | 15.4￠/kg + 149.5% |
| 2933.99.01 | 00 | Aromatic or modified aromatic: | | | | |
| 2933.99.01 | 00 | Butyl (R)-2-[4-(5-trifluoromethyl-2- pyridinyloxy)phenoxy]propanoate | kg | Free | | 15.4￠/kg + 50% |
| 2933.99.02 | 00 | 2-[4-[(6-Chloro-2-quinoxalinyl)oxy]phenoxy]- propionic acid, ethyl ester; and O,O-Dimethyl-S-[(4-oxo-1,2,3-benzotri- azin-3-(4H)-yl)methyl]phosphorodithioate | kg | Free | | 15.4￠/kg + 64.5% |
| 2933.99.16 | 00 | o-Diquat dibromide (1,1'-Ethylene- 2,2'-dipyridylium dibromide) | kg | Free | | 15.4￠/kg + 40.5% |
| 2933.99.55 | | Analgesics, antipyretics and nonhormonal anti-inflammatory agents | | 6.5% | Free (A*,AU,BH, CA,CL,E,IL,J,JO, K,MA,MX, P,SG) | 15.4￠/kg + 47.5% |
| 2933.99.55 | 20 | Tolmetin sodium dihydrate | kg | | | |
| 2933.99.65 | 00 | Anticonvulsants, hypnotics and sedatives | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 48.5% |
| 2934.10 | | Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure: | | | | |
| 2934.10.10 | 00 | Aromatic or modified aromatic: | | | | |
| 2934.10.70 | 00 | 4,5-Dichloro-2-n-octyl-4-isothiazolin-3-one; Ethyl 2-(2-aminothiazol-4-yl)-2- hydroxyiminoacetate; Ethyl 2-(2-aminothiazol-4-yl)-2- methoxyiminoacetate; 2-Methyl-4-isothiazolin- 3-one; 2-n-Octyl-4-isothiazolin-3-one; and Thiothiamine hydrochloride | kg | Free | | 30.5% |
| 2934.20 | | Compounds containing in the structure a benzothiazole ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2934.30 | | Compounds containing in the structure a phenothiazine ring-system (whether or not hydrogenated), not further fused: | | | | |
